Your browser doesn't support javascript.
loading
ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma.
Goltsov, Alexei A; Maru, Dipen M; Katkhuda, Riham; Duose, Dzifa Y; Luthra, Rajyalakshmi; Correa, Arlene M; Wang, Feng; Futreal, P Andrew; Hofstetter, Wayne L.
Affiliation
  • Goltsov AA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: agoltsov@mdanderson.org.
  • Maru DM; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Katkhuda R; Department of Pathology, University of Chicago Medical Center, Chicago, Illinois.
  • Duose DY; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Luthra R; Hematopathology-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Correa AM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang F; Computational Biology, The Janssen Pharmaceutical Companies of Johnson & Johnson, Shanghai, China.
  • Futreal PA; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hofstetter WL; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ann Thorac Surg ; 2023 Oct 06.
Article in En | MEDLINE | ID: mdl-37806335
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ann Thorac Surg Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Ann Thorac Surg Year: 2023 Document type: Article